Botanical and Plant-Derived Drugs: Global Markets

  • ID: 4430866
  • Report
  • Region: Global
  • 175 Pages
  • BCC Research
10 % OFF
until Apr 30th 2018
1 of 6
The Global Market for Botanical and Plant-Derived Drugs will Grow from $29.4 Billion in 2017 to around $39.6 Billion by 2022 with a CAGR of 6.1%

FEATURED COMPANIES

  • Abbott Laboratories
  • Chi-Med
  • Glaxosmithkline
  • Indus Biotech
  • Merlion Pharmaceuticals
  • Phytoquest Ltd
  • MORE

Report Includes

  • 27 tables
  • An overview of the botanical drug industry, with the overall plant-derived drug industry as a backdrop and the global market for these drugs going forward
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • A focus on legal, prescription-required therapeutic medicines sold in the open market; the study does not specifically cover herbals generally sold as dietary supplements (i.e., to promote overall “wellness” rather than to address specific medical conditions or symptoms)
  • Examination of the industry structure, competition, and market drivers
  • Discussion of market size and segmentation, including breakdowns of sales by therapeutic area and geographic area
  • Observations and conclusions regarding the future of the botanical and plant-derived drug industry

This report is an analytical business tool whose primary purpose is to describe the botanical drug industry with the overall plant-derived drug industry as a backdrop and the global market for these drugs going forward.

For the purposes of this report, botanicals are those drugs that are FDA-approved under the botanical drug pathway, while plant-derived drugs are both botanicals as well as other approved drugs that contain a mixture of natural plant-derived and synthetic or semisynthetic substances.

The study’s main focus is on legal, prescription-required therapeutic medicines sold in the open market. The study does not specifically cover herbals generally sold as dietary supplements (i.e., to promote overall “wellness” rather than to address a specific medical condition or symptoms). While there is a substantial market for these products, the medical value of many of these substances has not been demonstrated conclusively.

The Study Also Does Not Cover The Following:

  • Underground or illicit drugs.
  • Home remedies.
  • Tribal medicines.
  • Drugs derived from Archaea, bacteria and fungi (molds and yeasts).
  • Nonmedicinal plant substances, such as laxative cellulose and pectin fiber.
  • Intravenously delivered nutrients of plant origin, such as dextrose.
  • Plant-derived substances serving as pharmaceutical excipients, such as starch, methylcellulose, guar gum, vegetable oils, fatty acids, cocoa butter and candelilla wax.
  • Plant substances serving in cosmetics, toiletries and personal care products.
  • Microbial fermentation products, even those made with culture media incorporating corn steep liquor, starch or other plant-derived nutrients.
  • Marine life.

The Format Of The Study Is Organized Around The Following Topics:

  • Major types and applications of botanical drugs with plant-derived drugs as their backdrop.
  • Industry structure.
  • Market size and segmentation, including the breakdown of sales by therapeutic area and geographic area.
  • Market drivers.
  • Market projections through 2022.
  • Competition.
  • Observations and conclusions regarding the future of the botanical and plant-derived drug industry.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Chi-Med
  • Glaxosmithkline
  • Indus Biotech
  • Merlion Pharmaceuticals
  • Phytoquest Ltd
  • MORE

1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown

2: Summary and Highlights

  • Trends and Drivers for Botanical Drug Development
  • Table Summary : Global Market for Botanical and Plant-derived Drugs*, by Type, Through 2022
  • Figure Summary : Global Market for Botanical and Plant-derived Drugs*, by Type, 2016-2022

3: Market and Technology Background

  • Brief History of Plant-Derived Medicines
  • Opportunity Lies Beyond What Is Known
  • Getting Started
  • Key Drivers
  • Key Challenges
  • U.S. Government Investment
  • Industry Investment
  • Nutrition Science Partners Ltd. (Nestlé Health): A Case Study
  • Botanical Drugs Defined
  • Understanding the Regulatory Process
  • Investigational New Drug Applications
  • The First and Second U.S. Approved Botanical Drug
  • Botanical Candidates in the Pipeline
  • A Growing Pipeline
  • Overall Pharma Landscape
  • Major Classes of Plant Drugs
  • Intellectual Property
  • Production
  • A New Type of Production: Plant-Made Drugs
  • Drug Development and Manufacture

4: Market Breakdown by Technology Type

  • Sales of Plant-derived Drugs by Region
  • Plant-derived Drugs by Therapeutic Area
  • Value of Plant-derived Drugs by Therapeutic Area
  • A Pipeline Perspective: Composition of Botanical Drugs in Clinical Development

5: New Developments and Market Opportunities

  • Hormone Therapy and Metabolism Applications
  • Infectious Disease Applications
  • Pain and Central Nervous System Disease Applications
  • Cardiovascular and Metabolic Applications
  • Respiratory, Inflammation (Both Nonrelated and Related to Orthopedic) and Autoimmune Applications
  • Dermatology Applications
  • Gastrointestinal Applications
  • Oncology Applications
  • Botanical Drugs in Clinical Development

6: Company Profiles

  • Abbott Laboratories
  • Acorda Therapeutics Inc.
  • Amarex Clinical Research
  • Analyticon Discovery Gmbh
  • Artecef BV
  • Bayer Healthcare Pharmaceuticals
  • Bionorica Se
  • Bionumerik Pharmaceuticals Inc.
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cardax Pharmaceuticals
  • Chi-Med
  • Chong Kun Dang Pharmaceutical Corp.
  • Chung Mei Biopharma Co Ltd
  • Curapharm Inc.
  • Dong-A-St
  • Dongwha Pharm Co. Ltd.
  • Eisai Inc.
  • Ekomed Llc
  • Eli Lilly
  • Fytokem Products Inc.
  • Galapagos Nv
  • Glaxosmithkline
  • Glenmark Pharmaceuticals Limited
  • Green Cross Corp.
  • Green Laboratories Llc
  • GW Pharmaceuticals Plc
  • Hamida Pharma Inc.
  • Hanmi Pharma Co. Ltd.
  • Heterogeneity Llc
  • Hsrx Biopharmaceutical
  • Indena
  • Indus Biotech
  • Inmed Pharmaceuticals
  • Inspyr Therapeutics Inc.
  • Insys Therapeutics Inc
  • Izun Pharmaceuticals Corp.
  • Johnson & Johnson
  • Kanglaite USA Inc.
  • Lanzhou Foci Pharmaceuticals Co. Ltd.
  • Leo Pharma
  • Lupin Pharmaceuticals Inc.
  • Medigene Ag
  • Merck & Co. Inc.
  • Merlion Pharmaceuticals
  • Microbio Co. Ltd.
  • Mycosynthetix Inc.
  • Napo Pharmaceuticals Inc.
  • Novartis International AG
  • Pfizer
  • Pharmaceutical Plant Co.
  • Phynova
  • Phytomyco Research Pvt. Ltd.
  • Phytopharmacon Inc.
  • Phytoquest Ltd
  • Piramal Phytocare Ltd.
  • Prairie Plant Systems Inc.
  • Prana Therapeutics
  • Punisyn Pharmaceuticals Ltd. (Rimonest Ltd.)
  • Purapharm International Ltd.
  • Quercegen Pharmaceuticals Llc
  • Rottapharm (Madaus)
  • Sanofi
  • Santalis Pharmaceuticals
  • Schwabe Pharmaceuticals
  • Se-Cure Pharmaceuticals Ltd.
  • Sequoia Sciences Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Sun Ten Pharmaceutical Co. Ltd.
  • Tasly Pharmaceuticals Inc.
  • Tcm Biotech International Corp.
  • United Cannabis Corp.
  • Valeant Pharmaceuticals International Inc. (Salix Pharmaceuticals Inc.)
  • Vedic Lifesciences Pvt. Ltd.
  • Yiviva

7: Appendix

  • Table 26 : Plant-derived Drugs: Their Origin and Actions
  • Table 27 : Useful Resources for the Botanical Industry
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Chi-Med
  • Glaxosmithkline
  • Indus Biotech
  • Merlion Pharmaceuticals
  • Phytoquest Ltd
  • MORE

Analyst's Credentials:

Kim Lawson is a graduate of Mount Holyoke College with a degree in English Literature and an M.A. in management from Harvard University's extension program. She acquired experience as a healthcare journalist, including working for John Wiley & Sons as a print reporter, before serving as a research analyst in a small market research firm (in the Research Triangle Park area of North Carolina) that focused on pharmaceuticals and biotechnology. Before joining that firm, she published two reports on emerging and established diagnostics and therapeutics for benign and cancerous breast disease.

Note: Product cover images may vary from those shown
5 of 6
  • Abbott Laboratories
  • Acorda Therapeutics Inc.
  • Amarex Clinical Research
  • Analyticon Discovery Gmbh
  • Artecef BV
  • Bayer Healthcare Pharmaceuticals
  • Bionorica Se
  • Bionumerik Pharmaceuticals Inc.
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cardax Pharmaceuticals
  • Chi-Med
  • Chong Kun Dang Pharmaceutical Corp.
  • Chung Mei Biopharma Co Ltd
  • Curapharm Inc.
  • Dong-A-St
  • Dongwha Pharm Co. Ltd.
  • Eisai Inc.
  • Ekomed Llc
  • Eli Lilly
  • Fytokem Products Inc.
  • Galapagos Nv
  • Glaxosmithkline
  • Glenmark Pharmaceuticals Limited
  • Green Cross Corp.
  • Green Laboratories Llc
  • GW Pharmaceuticals Plc
  • Hamida Pharma Inc.
  • Hanmi Pharma Co. Ltd.
  • Heterogeneity Llc
  • Hsrx Biopharmaceutical
  • Indena
  • Indus Biotech
  • Inmed Pharmaceuticals
  • Inspyr Therapeutics Inc.
  • Insys Therapeutics Inc
  • Izun Pharmaceuticals Corp.
  • Johnson & Johnson
  • Kanglaite USA Inc.
  • Lanzhou Foci Pharmaceuticals Co. Ltd.
  • Leo Pharma
  • Lupin Pharmaceuticals Inc.
  • Medigene Ag
  • Merck & Co. Inc.
  • Merlion Pharmaceuticals
  • Microbio Co. Ltd.
  • Mycosynthetix Inc.
  • Napo Pharmaceuticals Inc.
  • Novartis International AG
  • Pfizer
  • Pharmaceutical Plant Co.
  • Phynova
  • Phytomyco Research Pvt. Ltd.
  • Phytopharmacon Inc.
  • Phytoquest Ltd
  • Piramal Phytocare Ltd.
  • Prairie Plant Systems Inc.
  • Prana Therapeutics
  • Punisyn Pharmaceuticals Ltd. (Rimonest Ltd.)
  • Purapharm International Ltd.
  • Quercegen Pharmaceuticals Llc
  • Rottapharm (Madaus)
  • Sanofi
  • Santalis Pharmaceuticals
  • Schwabe Pharmaceuticals
  • Se-Cure Pharmaceuticals Ltd.
  • Sequoia Sciences Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Sun Ten Pharmaceutical Co. Ltd.
  • Tasly Pharmaceuticals Inc.
  • Tcm Biotech International Corp.
  • United Cannabis Corp.
  • Valeant Pharmaceuticals International Inc. (Salix Pharmaceuticals Inc.)
  • Vedic Lifesciences Pvt. Ltd.
  • Yiviva
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll